Affinity Asset Advisors’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Other funds holding SLS
Affinity Asset Advisors's SLS Position: Q3 2026 in Review
Affinity Asset Advisors opened a new position in SELLAS Life Sciences (SLS) in Q3 2026: 50,000 shares worth $616K. The stake represents 0.03% of the portfolio and ranks #118 among its holdings.
210 funds tracked by Wall St. Rank hold SLS as of Q3 2026.
- Affinity Asset Advisors held 50,000 shares of SELLAS Life Sciences worth $616K as of Q3 2026.
- SELLAS Life Sciences was a new Affinity Asset Advisors position in Q3 2026.
- SELLAS Life Sciences made up 0.03% of Affinity Asset Advisors's portfolio in Q3 2026, its #118 holding.
- 210 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.
Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.